Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review.
Yeye ChenJiaqi ZhangCheng HuangZhenhuan TianXiaoyun ZhouChao GuoHongsheng LiuShanqing LiPublished in: Orphanet journal of rare diseases (2021)
For patients with resectable pLCNEC, multidisciplinary therapy based on surgery may have good survival benefits, and tumour stage is an independent risk factor for the prognosis of pLCNEC.
Keyphrases
- minimally invasive
- coronary artery bypass
- surgical site infection
- single cell
- pulmonary hypertension
- cell therapy
- case report
- stem cells
- percutaneous coronary intervention
- mesenchymal stem cells
- locally advanced
- radiation therapy
- bone marrow
- coronary artery disease
- free survival
- atrial fibrillation
- quality improvement
- liver metastases